which glp 1 should i take GLP-1 Medications for Weight Loss: How to Get Started | News Who Should Explore GLP-1 Shots

A 2024 study published in JAMA Ophthalmology reported that patients with Type 2 diabetes who took semaglutide-containing medications had more than a fourfold higher risk for developing non-arteritic anterior ischemic optic neuropathy (NAION) compared with patients not on a GLP-1 agonist

The FDA is reconsidering its decision to remove Eli Lillys drugs, Zepbound and Mounjaro, from the shortage list, temporarily allowing compounding facilities to continue producing alternative versions

For patients and clinicians alike, the label should prompt careful screening, not blanket avoidance

Most patients receive provider review and approval within 24 hours of completing the online health assessment